IT Services Q1 Review - BFSI Shows Signs Of Recovery, But The Sector Is Not Out Of The Woods Yet: DRChoksey

The brokerage remain positive on Infibeam Avenues, Tech Mahindra, and Sonata Software considering the deal wins, healthy quarterly results, improved management commentary,

(Image source: Representative/Unsplash)

NDTV Profit’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer NDTV Profit’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.

Deven Choksey Research Report

For Q1 FY25, the performance of IT companies within our coverage in revenue growth was broadly consistent with our estimates.

IT companies witnessed green shots in the BFSI segment, however, clients remain cautious about tech spending highlighting no to little pickup in discretionary spending.

Tier-1 companies witnessed revenue growth from North America and Europe. Management commentaries suggest that FY25E is likely to outperform FY24, with stronger growth anticipated in H2 FY25E compared to H1 FY25E.

Anticipation of better H2 FY25E performance is driven by growth across verticals and regions, deal ramp-ups, and a relatively lower base of FY24.

Employee attrition has bottomed out; all the IT companies are focusing on improving utilization and upskilling the current employee base.

The medium to long-term prospects are favorable, driven by higher deal wins, potential interest rate cuts that could boost latent demand, and growing momentum for Gen-AI, especially in areas such as automation, cloud migration, data modernization, and technology integration.

Top Picks:

We remain positive on Infibeam Avenues, Tech Mahindra, and Sonata Software considering the deal wins, healthy quarterly results, improved management commentary, and anticipation of stronger FY25E results against FY24.

Click on the attachment to read the full report:

Deven Choksey IT Q1FY25 Result Review.pdf
Read Document

Also Read: Pharma Sector Q1 Results Review - Select Bets To Continue To Perform: DRChoksey

DISCLAIMER

 This report is authored by an external party. NDTV Profit does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of NDTV Profit. 

Users have no license to copy, modify, or distribute the content without permission of the Original Owner.

lock-gif
To continue reading this story
Subscribe to Unlock & Enjoy your
Subscriber-Only benefits
Still Not convinced ?  Know More
Watch LIVE TV , Get Stock Market Updates, Top Business , IPO and Latest News on NDTV Profit.
GET REGULAR UPDATES